On Apr. 1, 2026, Eli Lilly announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for…
On Mar. 31, 2026, Biogen and Apellis Pharmaceuticals announced the companies have entered into a definitive agreement under…
On Mar. 31, 2026, Eli Lilly and Centessa Pharmaceuticals, a clinical-stage company developing a new class of medicines…
On Mar. 30, 2026, Biogen announced that the High Dose Regimen of SPINRAZA® (nusinersen), which is comprised of…
On Mar. 29, 2026, The South China Morning Post reported the cross-border outlicensing activities of Chinese biotech firms…
On Mar. 29, 2026, generative-AI drug developer Insilico Medicine announced that it has agreed to a global licensing…
On Mar. 27, 2026, a STAT survey conducted of nearly 1,000 National Institutes of Health (NIH) -supported scientists,…
On Mar. 27, 2026, Novartis announced an agreement to acquire Excellergy, a private biotech company developing next-generation anti-IgE…
On Mar. 27, 2026, A multi-institutional team of scientists, co-led by Northwestern University, has taken a crucial step…
On Mar. 27, 2026, measles cases in the United States have climbed to 1,575, with 88 new infections,…
On Mar. 27, 2026, Rocket Pharmaceuticals announced that the U.S. Food and Drug Administration(FDA) has granted accelerated approval…
On Mar. 26, 2026, the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (USPTO and PTAB,…
On Mar. 26, 2026, Indiana’s poultry industry continues to face significant challenges as outbreaks of highly pathogenic avian…
On Mar. 25, 2026, Merck, and Terns Pharmaceuticals, a clinical-stage oncology company, announced that the companies have entered…
On Mar. 25, 2026, researchers, led by scientists at the University of Yamanashi in Japan, cloned a single…
On Mar. 25, 2026, according to the latest data published by the World Health Organization (WHO), globally, 941,582…
On Mar. 24, 2026, researchers at the Francis Crick Institute report that the largest ancient DNA study of…
On Mar. 24, 2026, a study published in Nature describes how researchers are pulling clues from genetic material…
On Mar. 24, 2026, Governor Brian P. Kemp announced that global biopharmaceutical giant UCB, is planning a significant…
On Mar. 24, 2026, Pfizer and Valneva announced topline results from the Phase 3 VALOR “Vaccine Against Lyme…
On Mar. 23, 2026, it was reported that since the beginning of March, highly pathogenic avian influenza has…
On Mar. 20, 2026, Novartis announced an agreement with Synnovation Therapeutics, to acquire SNV4818, a pan-mutant‑selective PI3Kα inhibitor,…
On Mar. 20, 2026, the South China Morning Post reported that celebrated scientist Shu Xiaokun, Ph.D. leaves prestigious…
On Mar. 20, 2026, researchers of a Rutgers Health–led study led by Holly Poore, a faculty instructor of psychiatry…
On Mar. 19, 2026, the University of Southern Denmark announced it has placed a “full hold” on a…
On Mar. 19, 2026, The U.S. Food and Drug Administration approved a 7.2-milligram dose of Danish drugmaker Novo…
On Mar. 19, 2026, the U.S. Centers for Disease Control and Prevention announced that as of February 11,…
On Mar. 19, 2026, a nationwide STAT survey of federally funded researchers reveals that, a year after Donald…
On Mar. 18, 2026, Nia Therapeutics announced that the U.S. Food and Drug Administration has granted Breakthrough Device…
On Mar. 18, 2026, the National Institutes of Health (NIH) announced more than $150 million to develop and…